PharmaCorp Announces Grant of Stock Options

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article contentSASKATOON, Saskatchewan, March 04, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 213,519 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.44 and ‎an expiry date of March 2, 2036, subject to approval of the TSX Venture Exchange.Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentThe Corporation relied on section 5.5(b) of Multilateral Instrument 61-‎‎101 as the exemption from ‎the formal valuation requirements of MI 61-101 in respect of the grant of ‎options to the directors and officers of ‎the Corporation, as the common shares of the Corporation are not ‎listed on a specified market (and ‎the common shares are only listed on the TSXV). ‎The Corporation relied on ‎section 5.7(a) of MI 61-101 as the exemption from the minority approval ‎requirements of MI 61-‎‎101 in respect of the grant of options to the directors and officers of the‎ Corporation as neither the fair market ‎value of the subject matter of, nor the fair market value of the ‎consideration for, the grant of the ‎options to the directors or officers of the Corporation exceeded 25% of the ‎Corporation’s market capitalization.Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contentArticle contentAbout PharmaCorp Rx Inc.Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentPharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support, and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner. PharmaCorp currently operates seven PharmaChoice Canada bannered pharmacies and will continue to acquire both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada. PharmaCorp shares trade on the TSX Venture Exchange under the symbol: PCRX.Article contentPharmaCorp actively welcomes discussions with pharmacy owners considering succession or sale. For more information about our acquisition program and process, please visit www.PharmaCorpRx.ca or contact our team confidentially. We are committed to seamless transitions that protect your legacy and serve your community.Article contentFor further information, please contact:Article contentInvestor Relationsinfo@pharmacorprx.caTel: (306) 536-3771Article contentNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Article contentArticle contentArticle contentArticle contentArticle contentArticle contentTrending Posthaste: This dormant pipeline needs to be restarted for the sake of Canada, economists say News Bank of Canada governor warns of growing risks to financial stability Economy Legal fight over propane terminal clouds Canada's energy export push Energy Mortgage renewal headwinds near a ‘turning point’ for pandemic buyers, report says Mortgages Housing affordability improves yet again, though not for the right reasons Real Estate Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Posthaste: This dormant pipeline needs to be restarted for the sake of Canada, economists say News Bank of Canada governor warns of growing risks to financial stability Economy Legal fight over propane terminal clouds Canada's energy export push Energy Mortgage renewal headwinds near a ‘turning point’ for pandemic buyers, report says Mortgages Housing affordability improves yet again, though not for the right reasons Real Estate